Karyopharm Therapeutics, Inc. (KPTI)
8.82
-0.33
(-3.61%)
USD |
NASDAQ |
Mar 05, 16:00
8.77
-0.05
(-0.57%)
After-Hours: 20:00
Karyopharm Therapeutics Cash from Investing (TTM) : 43.38M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 436.33M |
| Baxter International, Inc. | 2.841B |
| Bruker Corp. | -196.50M |
| Catalyst Pharmaceuticals, Inc. | -0.058M |
| Agios Pharmaceuticals, Inc. | 377.18M |